DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis

Decoy receptor 3 (DcR3) is abnormally up-regulated in many cancer cells. It may help cancer cells to escape from immune surveillance and establish metastatic lesions. However, whether DcR3 can be used as a biomarker for the diagnosis of cancer metastasis is unclear. In this study, sera from healthy...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Li, Junxin, Xie, Ni, Yuan, Jianhui, Liu, Lvyan, Zhou, Qiming, Ren, Xiaohu, Chen, Qian, Zhang, Guizhong, Ruan, Qingguo, Chen, Youhai H., Wan, Xiaochun
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746094/
https://ncbi.nlm.nih.gov/pubmed/29296192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22544
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires